Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cresco Labs (CRLBF) EBT Margin (2020 - 2026)

Cresco Labs filings provide 7 years of EBT Margin readings, the most recent being 1.85% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 129.0% to 1.85% in Q1 2026 year-over-year; TTM through Mar 2026 was 15.17%, a 1128.0% decrease, with the full-year FY2025 number at 14.55%, down 1308.0% from a year prior.
  • EBT Margin hit 1.85% in Q1 2026 for Cresco Labs, up from 53.94% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 8.65% in Q1 2024 to a low of 78.6% in Q4 2022.
  • Median EBT Margin over the past 5 years was 0.55% (2025), compared with a mean of 12.19%.
  • The widest YoY moves for EBT Margin: up 13538bps in 2022, down -8393bps in 2022.
  • Cresco Labs' EBT Margin stood at 78.6% in 2022, then surged by 109bps to 6.81% in 2023, then plummeted by -74bps to 1.74% in 2024, then crashed by -3206bps to 53.94% in 2025, then surged by 97bps to 1.85% in 2026.
  • The last three reported values for EBT Margin were 1.85% (Q1 2026), 53.94% (Q4 2025), and 6.13% (Q3 2025) per Business Quant data.